-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Collegium Pharmaceutical, Raises Price Target to $60

Benzinga·01/09/2026 11:38:54
Listen to the news
HC Wainwright & Co. analyst Brandon Folkes reiterates Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and raises the price target from $46 to $60.